Synovus Financial’s DexCom DXCM Stock Holding History

Synovus Financial’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-17,663	Closed	-$1.65M	–	837
2023 Q3	$1.65M	Sell	17,663 -3,447	-16%	-$389K	0.02%	365
2023 Q2	$2.71M	Sell	21,110 -905	-4%	-$109K	0.03%	297
2023 Q1	$2.56M	Buy	+22,015	New	+$2.46M	0.03%	298
2021 Q2	–	Sell	-6,316	Closed	-$564K	–	838
2021 Q1	$564K	Buy	6,316 +632	+11%	+$59.3K	0.01%	522
2020 Q4	$520K	Buy	5,684 +160	+3%	+$14.3K	0.01%	533
2020 Q3	$569K	Buy	5,524 +2,224	+67%	+$232K	0.01%	461
2020 Q2	$335K	Buy	3,300 +912	+38%	+$81.6K	﹤0.01%	553
2020 Q1	$162K	Buy	2,388 +2,332	+4,164%	+$145K	﹤0.01%	809
2019 Q4	$3K	Buy	+56	New	+$2.66K	﹤0.01%	1368
2019 Q2	–	Sell	-48	Closed	-$1K	–	1386
2019 Q1	$1K	Hold	48	–	–	﹤0.01%	1385
2018 Q4	$1K	Sell	48 -1,408	-97%	-$44.7K	﹤0.01%	1353
2018 Q3	$52K	Hold	1,456	–	–	﹤0.01%	830
2018 Q2	$35K	Hold	1,456	–	–	﹤0.01%	846
2018 Q1	$27K	Buy	+1,456	New	+$21.5K	﹤0.01%	872

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Synovus Financial's DXCM Position: Q4 2023 in Review

Synovus Financial sold out of DexCom (DXCM) in Q4 2023, closing a stake of 17,663 shares — an estimated $1.65M sold.

Synovus Financial first reported a position in DXCM in Q1 2018 and held it in 14 quarters. The position peaked at $2.71M in Q2 2023. 975 funds tracked by Wall St. Rank hold DXCM as of Q4 2023.

Synovus Financial reported no remaining DexCom position as of Q4 2023 after selling out during the quarter.
Synovus Financial sold 17,663 DexCom shares in Q4 2023, an estimated $1.65M.
Synovus Financial first reported a position in DexCom in Q1 2018 and held it in 14 quarters.
Synovus Financial's DexCom position peaked at $2.71M in Q2 2023.
975 funds tracked by Wall St. Rank held DexCom as of Q4 2023.

Based on Synovus Financial's 13F filing for Q4 2023, filed 14 Feb 2024.